D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$446M |
| 2 |
SLB Ltd
SLB
|
+$276M |
| 3 |
Apple
AAPL
|
+$267M |
| 4 |
Johnson & Johnson
JNJ
|
+$244M |
| 5 |
TJX Companies
TJX
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$304M |
| 2 |
Amazon
AMZN
|
+$289M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$274M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$204M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.17% |
| 2 | Healthcare | 10.73% |
| 3 | Financials | 9.55% |
| 4 | Consumer Discretionary | 9.16% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Royal Caribbean
RCL
$78.7B
| $27.1M | 0.05% |
+276,324
| New | +$25.8M |
|
|
WBMD
452
DELISTED
WebMD Health Corp.
WBMD
| $27.1M | 0.05% |
514,193
+53,936
| +12% | +$2.75M |
|
|
CST
453
DELISTED
CST Brands, Inc.
CST
| $27.1M | 0.05% |
562,646
-24,898
| -4% | -$1.2M |
|
|
HRC
454
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $27M | 0.05% |
381,915
-123,765
| -24% | -$7.88M |
|
455
Zebra Technologies
ZBRA
$12.4B
| $26.8M | 0.05% |
293,344
-10,671
| -4% | -$925K |
|
|
ZIONW
456
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $26.6M | 0.05% |
2,308,700
+160,000
| +7% | +$1.96M |
|
457
Plains GP Holdings
PAGP
$5.23B
| $26.6M | 0.05% |
849,491
+455,319
| +116% | +$14.8M |
|
458
F5
FFIV
$22.1B
| $26.5M | 0.05% |
186,057
-98,992
| -35% | -$14.1M |
|
459
BioCryst Pharmaceuticals
BCRX
$2.37B
| $26.5M | 0.05% |
3,153,628
-529,523
| -14% | -$3.68M |
|
|
FDC
460
DELISTED
First Data Corporation
FDC
| $26.4M | 0.05% |
1,706,497
+1,405,848
| +468% | +$22.1M |
|
461
Marriott International
MAR
$98.7B
| $26.4M | 0.05% |
280,791
-278,093
| -50% | -$24.2M |
|
|
RHT
462
DELISTED
Red Hat Inc
RHT
| $26.4M | 0.05% |
305,004
-151,845
| -33% | -$12.1M |
|
463
Zions Bancorporation
ZION
$10.1B
| $26.4M | 0.05% |
628,044
+428,602
| +215% | +$18.6M |
|
|
K
464
DELISTED
Kellanova
K
| $26.3M | 0.05% |
386,258
+152,503
| +65% | +$10.5M |
|
465
CALL
Qualcomm
QCOM
$176B
| $26.2M | 0.05% |
457,600
-233,100
| -34% | -$13.5M |
|
466
Teck Resources
TECK
$29.5B
| $26.1M | 0.05% |
1,196,485
+243,999
| +26% | +$5.45M |
|
|
P
467
DELISTED
Pandora Media Inc
P
| $26.1M | 0.05% |
2,208,035
-947,917
| -30% | -$11.9M |
|
468
PUT
Freeport-McMoran
FCX
$90B
| $25.8M | 0.05% |
1,934,000
+45,600
| +2% | +$655K |
|
|
PTLA
469
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $25.7M | 0.05% |
655,490
+582,397
| +797% | +$18.5M |
|
470
LiveRamp
RAMP
$2.29B
| $25.6M | 0.05% |
898,715
+123,322
| +16% | +$3.43M |
|
|
FOLD
471
DELISTED
Amicus Therapeutics
FOLD
| $25.5M | 0.04% |
3,581,938
+1,251,339
| +54% | +$7.91M |
|
472
CALL
CVS Health
CVS
$137B
| $25.4M | 0.04% |
324,100
+91,300
| +39% | +$7.29M |
|
473
CALL
Broadcom
AVGO
$1.82T
| $25.4M | 0.04% |
1,161,000
+111,000
| +11% | +$2.29M |
|
474
Alnylam Pharmaceuticals
ALNY
$36.3B
| $25.4M | 0.04% |
495,394
+279,968
| +130% | +$12.9M |
|
|
MDR
475
DELISTED
McDermott International
MDR
| $25.3M | 0.04% |
1,250,458
+576,267
| +85% | +$12.7M |
|
Similar funds
D.E. Shaw & Co's Q1 2017 Portfolio in Review
As of Q1 2017, D.E. Shaw & Co held 3,844 positions worth $56.9B, down 3.4% from $58.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
D.E. Shaw & Co withdrew a net $5.64B in Q1 2017, closing 599 positions and reducing 1,534 holdings. Its most notable exit was Dick's Sporting Goods, an estimated $62.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, D.E. Shaw & Co opened a new position in C&J Energy Services, Inc. worth $131M.
- D.E. Shaw & Co's largest Q1 2017 buy was C&J Energy Services, Inc.: 3,857,413 shares worth $131M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $446M increase.
- D.E. Shaw & Co's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $304M.
- D.E. Shaw & Co fully exited Dick's Sporting Goods in Q1 2017, selling an estimated $62.3M.
- D.E. Shaw & Co's ten largest holdings make up 9.7% of its $56.9B portfolio in Q1 2017.
- D.E. Shaw & Co opened 437 new positions and closed 599 in Q1 2017.
- D.E. Shaw & Co's portfolio value fell 3.4% quarter-over-quarter to $56.9B.
Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.